J&J Creates ONE China OTC As Country’s Largest Consumer Health Firm
This article was originally published in The Tan Sheet
Executive Summary
Merging Shanghai Johnson & Johnson and Xian Janssen business divisions makes ONE China OTC the largest consumer health care product company in China. The move “is part of a broader Johnson & Johnson strategic initiative to leverage the company’s breadth and scale in China,” says Mike Hsu, ONE China OTC general manager.